| Literature DB >> 25885004 |
Julian F Maempel1, Fraser Riddoch, Neville Calleja, Ivan J Brenkel.
Abstract
BACKGROUND ANDEntities:
Mesh:
Year: 2015 PMID: 25885004 PMCID: PMC4513600 DOI: 10.3109/17453674.2015.1040304
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Figure 1.Patients included in the study.
Percent complications in each age group (unadjusted)
| Group 1 | Group 2 | Group 3 | Overall | |
|---|---|---|---|---|
| Blood transfusion | 6.6 | 11 | 17 | 8.8 |
| Urinary catheterization | 18 | 28 | 50 | 22 |
| Acute confusion (admission) | 0.6 | 2.2 | 3.1 | 1.2 |
| Cardiac arrhythmia (admission) | 0.4 | 1.0 | 2.2 | 0.8 |
| LRTI (1 month) | 0.9 | 2.3 | 1.6 | 1.3 |
| ACS (1 month) | 0.4 | 1.1 | 0.6 | 0.5 |
| DVT/PE (1 month) | 1.0 | 0.6 | 0.9 | 0.9 |
| Deep infection (1 year) | 1.1 | 2.0 | 1.7 | 1.4 |
| Revision (1 year) | 0.5 | 0.7 | 0.3 | 0.5 |
| MUA (1 year) | 1.8 | 0.3 | 0 | 1.3 |
LRTI: lower respiratory tract infection;
ACS: acute coronary syndrome;
DVT/PE: deep-vein thrombosis/pulmonary embolism;
MUA: manipulation under anesthetic.
Mean hemoglobin concentration (SD) in the 3 groups
| Hb, g/dL | Group 1 | Group 2 | Group 3 | p-value |
|---|---|---|---|---|
| Preop. | 13.8 (1.4) | 13.4 (1.4) | 13.0 (1.4) | < 0.001 |
| Postop. | 11.6 (1.5) | 11.1 (1.4) | 10.7 (1.5) | < 0.001 |
| Change | −2.2 (0.99) | −2.3 (0.98) | −2.3 (1.2) | 0.2 |
ANOVA.
Figure 2.Median length of stay throughout the study period. This was higher in the elderly (p < 0.001) but all 3 groups showed a reduction in median length of stay over the study period.
Adjusted odds ratios and p-values after binary logistic regression, for blood transfusion, urinary catheterization requirements, and incidence of early postoperative complications, according to age. Group 1 was used as the reference group
| Adjusted Odds ratio (95% CI) | Co-variates | |||
|---|---|---|---|---|
| Group 2 | Group 3 | p-value | adjusted for | |
| Blood transfusion | 1.4 (0.99–1.9) | 1.8 (1.3–2.6) | 0.004 | Preop. Hb., ASA |
| Urinary catheterization | 1.8 (1.5–2.3) | 2.4 (1.8–3.1) | < 0.001 | Sex, ASA |
| Acute confusion | 3.3 (1.5–7.2) | 4.3 (1.9–9.8) | 0.001 | ASA |
| Cardiac arrhythmia | 3.4 (1.6–7.2) | 4.6 (2.0–10.6) | < 0.001 | Preop. Hb |
Orthopedic complications occurring within 1 year of surgery. Group 1 was used as the reference group
| Odds ratio (95% CI) | |||
|---|---|---|---|
| Group 2 | Group 3 | p-value | |
| Deep infection | 1.8 (0.9–3.6) | 1.5 (0.6–4.1) | 0.3 |
| Revision | 1.4 (0.4–4.4) | 0.7 (0.1–5.6) | 0.8 |
| MUA | 0.2 (0.04–0.77) | N/A | 0.02 |
2 × 2 chi-squared test for patients in groups 1 and 2.
Preoperative American Knee Society knee score (AKSK), preoperative American Knee Society function score (AKSF), and postoperative AKSK and AKSF scores at 12–18 months
| AKSK | AKSF | |||
|---|---|---|---|---|
| preop. | 12–18 month | preop. | 12–18 month | |
| Group 1 | 37 (15) | 92 (2–100) | 65 (0–100) | 80 (0–100) |
| Group 2 | 36 (16) | 93 (25–100) | 60 (10–100) | 80 (0–100) |
| Group 3 | 36 (17) | 93 (35–100) | 55 (0–90) | 65 (0–100) |
| p-value | 0.7 | 0.001 | < 0.001 | < 0.001 |
mean (SD)
median (range)
ANOVA
Kruskal-Wallis test.